Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome

Clinical trial NCT07770282 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07770282
Sponsor: All India Institute of Medical Sciences, Bhubaneswar
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenia Disorder Metabolic Syndrome Antipsychotic-induced Weight Gain Cardiovascular Risk Insulin Resistance

Start date: 2026-12-01
Primary completion: 2030-07-30
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.